InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 2.03 USD 18.71% Market Closed
Market Cap: 119.5m USD
Have any thoughts about
InflaRx NV?
Write Note

P/OCF
Price to OCF

-2.7
Current
-2.5
Median
23.4
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-2.7
=
Market Cap
119.5m USD
/
Operating Cash Flow
-42.2m EUR
All Countries
Close
Market Cap P/OCF
DE
InflaRx NV
NASDAQ:IFRX
119.5m USD -2.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 773.4
US
Abbvie Inc
NYSE:ABBV
299.8B USD 18.2
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD -132.1
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -475.1
AU
CSL Ltd
ASX:CSL
137.3B AUD 32
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 20.3
US
Seagen Inc
F:SGT
39.3B EUR -76.7
NL
argenx SE
XBRU:ARGX
34B EUR -137.9
 
DE
InflaRx NV
NASDAQ:IFRX
Average P/OCF: 20.8
Negative Multiple: -2.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 773.4
US
Abbvie Inc
NYSE:ABBV
18.2
US
Amgen Inc
NASDAQ:AMGN
21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -132.1
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.1
AU
CSL Ltd
ASX:CSL
32
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -137.9

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More